We investigated the cutaneous expression of genes and enzymes responsible for the multistep conversion of tryptophan to serotonin and further to melatonin. Samples tested were human skin, normal and pathologic (basal cell carcinoma and melanoma), cultured normal epidermal and follicular melanocytes, melanoma cell lines, normal neonatal and adult epidermal and follicular keratinocytes, squamous cell carcinoma cells, and fibroblasts from dermis and follicular papilla. The majority of the samples showed simultaneous expression of the genes for tryptophan hydroxylase, arylalkylamine N-acetyltransferase (AANAT), and hydroxyindole-Omethyltransferase (HIOMT). The products of AANAT activity were identified by RP-HPLC with fluorimetric detection in human skin and in cultured normal and malignant melanocytes and immortalized keratinocytes; HIOMT activity was detected in human skin, keratinocytes, and melanoma cells. N-acetylserotonin (NAS) was detected by RP-HPLC in human skin extracts. NAS identity was confirmed further by LC/MS in keratinocytes. In conclusion, we provide evidence that the human skin expresses intrinsic serotonin and melatonin biosynthetic pathways.
MATERIALS AND METHODS

Tissue
Human tissues consisted of non-lesional skin and pathologic skin, such as basal cell carcinoma or invasive melanoma. In addition, specimens of pituitary, adrenal gland, and myometrium were also included in the experiments. Skin and adrenal gland were collected from tissue removed during surgery, whereas pituitaries were obtained from the National Hormone and Pituitary Program (NIDDK). The use of human tissues was approved by the University of Tennessee Health Science Center (UTHSC) Committee on Research Involving Human Subjects.
Cell culture
Human skin cells included normal neonatal keratinocytes, adult epidermal and follicular melanocytes and keratinocytes, and dermal and follicular papilla fibroblasts. Established human skin cell lines included immortalized keratinocytes (HaCaT), squamous cell carcinoma (C 4-1 ), immortalized normal epidermal melanocytes PIG1, and six melanoma lines. Those included SKMEL188, which express an amelanotic phenotype when cultured in Ham's F10 medium, and become melanotic in Dulbecco's modified Eagle medium (DMEM) (22) . Other human melanoma lines were established from radial growth phase (WM 35 and SBCE2), vertical growth phase (WM 98 and WM 1341D), and metastasis (WM 164) (gift of M. Herlyn, Wistar Institute, Philadelphia, PA). The established cell lines were cultured according to standard protocols in medium containing 10% fetal bovine serum (FBS) and antibiotics (GIBCO, Rockville, MD) in the presence of 5% C0 2 as described previously (22) . The culture media were Ham's F10 for SKMEL188, DMEM (GIBCO) for WM 35, SBCE2, WM 98, WM 1341D, and WM164 melanoma cells. Media were changed every second day (22) .
Normal human neonatal keratinocytes from passages 2 and 3 were used for experiments (23) . Primary cell cultures were established from foreskin as described previously (23) . The cells were propagated in low-calcium (0.15 mM) serum-free Keratinocyte Growth Medium (KGM), which contained bovine pituitary extract (BPE), rEGF, and antibiotics (Clonetics Corp., San Diego, CA). Immortalized human melanocytes (PIG1) (gift of C. LePoole, Loyola Medical Center, Maywood, IL) were cultured in medium 154 (Cascade Biologicals, Portland, OR) supplemented with 5% FBS, 13 µg/ml BPE, 8 nM phorbol 12-myristate 13-acetate (TPA), 1 µg/ml α-tocopherol, 0.6 ng/ml basic fibroblast growth factor, 1 µg/ml transferrin, and 5 µg/ml insulin (all from Sigma, St. Louis, MO) (24) .
Adult epidermal and hair follicle melanocytes and keratinocytes, dermal fibroblasts, and follicular papilla fibroblasts cultures were established from normal scalp specimens, obtained with informed consent after elective plastic surgery, under protocols described previously (25) (26) (27) . Epidermal and follicular melanocytes were cultured in medium composed of Eagle's Modified Essential Medium (EMEM) [(supplemented with 5% fetal calf serum (FCS), 50 nM 12-O-tetradecanoylphorbol-13-acetate (Sigma), and 1 × 10 -9 M cholera toxin (ICN, Ohio)] and K-SFM [supplemented with 25 µg/ml bovine pituitary extract and 0.2 ng/ml rEGF, (Gibco, BRL)]. Epidermal and follicular keratinocytes were maintained in K-SFM medium supplemented as above.
Dermal fibroblasts were cultured in RPMI 1640 (Gibco BRL) supplemented with 10% FCS. Follicular papillae were isolated by microdissection from scalp hair follicles as previously described (27) . Isolated papillae, attached to the culture dish surface and grown in RPMI 1640 (Gibco BRL), were supplemented with 10% FCS.
After being washed with phosphate buffered saline (PBS), human melanoma cells were detached by using Ca 2+ and Mg 2+ free Tyrode's solution containing 1 mM ethylene diamine tetraacetate (EDTA) while normal and immortalized keratinocytes, squamous cell carcinoma cells, fibroblasts, and melanocytes were trypsinized. The cells were centrifuged and frozen until further analyses.
Ultraviolet irradiation of cells was performed as described previously (28) . Briefly, cells were cultured in 9-cm Petri dishes at concentration 10 6 cells/dish and, before irradiation, medium was aspirated and substituted by 10 ml of PBS. The dishes were placed on the UV transilluminator 2000 (BioRad, Hercules, CA) and incubated as described previously (28) . Time of exposure and corresponding doses as well as the spectrum of UV were established previously (28) . After irradiation, PBS was substituted by standard culture medium, cells were incubated for 24 h and then detached, collected, and processed for RNA isolation.
RNA extraction and cDNA preparation
Total RNA was extracted by using Trizol isolation kit (Gibco-BRL). The synthesis of first-strand cDNA was performed by using the Superscript preamplification system (Gibco-BRL). RNA (5 µg) per reaction was reverse-transcribed according to the manufacturer's protocol by using oligo (dT) as the primer.
All samples were standardized for the analysis by the amplification of housekeeping gene GAPDH as described previously (28) . Human TPH, AANAT, and HIOMT genes were amplified by nested polymerase chain reaction (PCR). The localization of the primers in corresponding genes is presented in Figure 1A . The reaction mixture (25 µl) contained 2.5 mM MgCl 2 , 2.5 mM of each dNTP, 0.4 µM of each primer, 75 mM Tris-HCl (pH 8.8), 20 mM (NH 4 ) 2 Human TPH cDNA amplification was performed as follows. Primers P100 and P101 were used in the first round of amplification. Sequences of primers were as follows: P100 5'-AGCCAGATACCTGCCATGAAC-3'; P101 5'-GCTGCAGCTCATTCATGGCAC-3'. Aliquot of PCR mixture from the first round of amplification was transferred to a new tube and a second round of PCR was conducted. Primers for the second round of PCR were P106 5'-CCAAGAAATTGGCTTGGCTTCTC-3'; P107 5'-TGCTCTTGGTGTCTTTCAGGATC-3'.
The first round of amplification of human AANAT was conducted by using 2 µl of cDNA and primers P122 (5'-TGCCAGTGAGTTTCGCTGCCTC-3') and P123 (5'-ACCTGTGCAGCGTCAGTGACTC-3'). Primers P124 (5'-GCCTTTGAGATCGAGCGTGAAG-3') and P125 (5'-GCATGAGTCTCTCCTTGTCCCAG-3') were used in the second round of amplification.
Primers for the first round of human HIOMT gene amplification were P118 (5'-TGAGAGAAGGAAGGAACCAGTAC-3') and P119 (5'-CAAGTGTGGTAGATCCTCTCCAG-3'); and for the second one, P120 (5'-GAAGAGCTTTTTACGGCCATCTAC-3') and P121 (5'-CGGAAGAGGGTCTTTGAAGAAATC-3').
Amplification products were separated by agarose electrophoresis and visualized by ethidium bromide staining according to standard protocol used in our laboratory (28) .
Sequencing
The identified PCR products were excised from the agarose gel and purified by GFX PCR DNA and gel band purification kit (Amersham-Pharmacia-Biotech, Piscataway, NJ). PCR products were sequenced from both ends. Alternatively, PCR fragments were cloned in pGEM-T easy vector system (Promega) and purified by plasmid purification kit (Qiagen, Hilden, Germany). Sequencing was performed in the Molecular Resource Center at the University of Tennessee HSC (Memphis) by using Applied Biosystems 3100 Genetic Analyzer and BigDye™ Terminator Kit.
Radiometric assay for tryptophan hydroxylase
The radiometric assay for tryptophan hydroxylase was performed according to the method described by Beevers et al. (29) , in 50 mM Tris buffer containing 2 mM dithiothreitol, 100 µM L-tryptophan, ~10 nM L- [5- 3 H]tryptophan as radioactive tracer (~100,000 cpm, 31 Ci/mmol, Amersham Life Sciences Inc., Arlington Heights, IL), 0.5 mM 6-methyl-5,6,7,8-tetrahydropterine and crude cell homogenate containing 30-50 µg protein.
High-performance liquid chromatography (HPLC)
Separation and detection of biogenic amines and indole compounds followed two methods (e.g., electrochemical detection and fluorimetric detection). In the first method, separation and detection of serotonin and 5-hydroxyindole acetic acid was as previously published (30, 31) . Cell pellets were sonicated in 200 µl phosphate buffer, centrifuged, and filtered, and the supernatant was injected onto the column. The system consisted of an Altex 110 A metering pump, a Rheodyne 7125 inject port with a 50 µl loop, and a Microsorb C18 reverse-phase column (100 mm × 4.6 mm I.D., 3-µm particle size) (Rainin Instruments, Woburn, MA). The amperometric detector was a Bioanalytical Systems LC-4B electrochemical controller with an LC-17 transducer consisting of a glassy carbon working electrode and a Ag/AgC1 reference electrode. The potential of the working electrode was set at +0.80 V relative to the reference electrode. The solvent system consisted of 0.1 M sodium phosphate (pH 4.60) mixed with HPLC-grade methanol (7% v/v) and delivered at a rate of 0.6 ml/min. The mobile phase was made up daily, filtered through Nylon-66 filters (0.45-µm pore size), and de-gassed under vacuum before use. Stock solutions (1 mg/ml) of standards (Sigma) were made up in distilled water with 0.1% ascorbic acid added.
In the second method, we used fluorimetric detection system for separation of products of AANAT and HIOMT reactions (see below).
AANAT activity was measured by modifying the method described by Thomas et al. (32) . Cells were homogenized with a glass homogenizer in an ice-cold 0.25 M potassium phosphate buffer (pH 6.8) containing 1 mM DL-dithiothreitol (DTT), 1 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), protease inhibitor cocktail (2 µl/ml homogenization mixture), and 0.625 mM acetyl coenzyme A. Homogenates were centrifuged at 15 000 × g for 10 min at 4 û C. To measure enzymatic activity aliquots of 80 µl of supernatant were mixed with 20 µl of 5 mM serotonin or tryptamine in 0.25 M potassium phosphate buffer (pH 6.8). The final concentrations of acetyl coenzyme A and amine substrate were 0.5 mM and 1 mM, respectively. The mixtures were then incubated for 1 h at 37 û C, and the enzymatic reaction was stopped by the addition of 20 µl of 6M HClO 4 . After centrifugation in microcentrifuge at 4ûC, the supernatant (30-35 µl) was subjected to HPLC in a system equipped with a Novapak C 18 reverse-phase column (100 × 5 mm, i.d.) and fluorometric detector (Waters, Milford, MA). The detector was calibrated with excitation and emission wavelengths set at 285 and 360 nm, respectively. The elution was carried out isocratically at ambient temperature with a flow rate 1.5 ml/min for the different mobile phases depending on the amine substrate used. The mobile phase contained 4 mM sodium 1-octanesulfonate as ion-pairing agent, 50 mM ammonium formate (pH 4.0) versus methanol (80:20) for serotonin and (75:25) for tryptamine. Elution peaks of N-acetylserotonin and N-acetyltryptamine were identified by retention time. Their identity was verified by their coelution with authentic standards. Comparing the peak areas with known concentrations of standards made quantitative determination of N-acetylserotonin and N-acetyltryptamine. For the background controls, the reaction mixture was incubated without substrates or without an enzyme source.
HIOMT activity was assayed by a modification of the method for the first time described by Itoh et al. 1997 (33) and based on HPLC separation and fluorometric detection of melatonin formed enzymatically from N-acetylserotonin and S-adenosyl-L-methionine. Briefly, cells were homogenized with a glass homogenizer in an ice-cold 0.05 M sodium phosphate buffer (pH 7.9) containing 0.625 mM S-adenosyl-L-methionine. Homogenates were centrifuged at 15 000 × g for 10 min at 4 û C. Aliquots of 80 µl of supernatant were mixed with 20 µl of 5 mM Nacetylserotonin in 0.05 M sodium phosphate buffer (pH 7.9). The final concentrations of Sadenosyl-L-methionin and N-acetylserotonin were 0.5 mM and 1 mM, respectively. The mixtures were then incubated for 1 h at 37 û C, and the enzymatic reaction was stopped by the addition of 20 µl of 6M HClO 4 . After centrifugation in microcentrifuge at 4ûC, the supernatant (60 µl) was subjected to HPLC in a system described above for measurement of AANAT activity with tryptamine as substrate. Elution peaks of N-acetylserotonin and melatonin were identified by retention time. Their identity was verified by their co-elution with authentic standards. Comparing the peak areas with known concentrations of standard made quantitative determination of melatonin. For the background controls, the reaction mixture was incubated without substrate or without an enzyme source. Protein concentration was determined by a dyebinding method with BSA as the standard (35) .
Liquid chromatography/mass spectrometry (LC/MS)
We analyzed the samples by using LC-MS, a model L-7000 HPLC system and M-8000 LC/3DQ-MS quadraopole ion trap mass spectrometer (Hitachi Instruments, Inc., San Jose, CA), in the tandem mode. Briefly, cell pellets of HaCaT keratinocytes were suspended in 0.03 N perchloric acid containing 40 µM pargyline at ration 17-20 × 10 7 cells per ml. The extracts were sonicated, centrifuged for 10 min at 15,000 g and supernatants were filtered through a Millex-LH filter (0.45-µm pore size). Aliquots (50 µl) were separated by RP-HPLC on a Hitachi L-7000 System through a C18 Wydac column (250 × 2 mm; 5-µm particle size; 300 angstrom pore size; cat #218TP52) (Hesperia, CA) with a mobile phase A, water with 0.2% acetic acid; and separating phase B, methanol with 0.2% acetic acid. We performed separation with methanol at gradients 5% (0-5 min), 90% (5-40 min), and 90% (40-45 min), while maintaining the flow rate at 0.3 ml/min. The effluent from the HPLC system was routed to the MS through atmospheric pressure chemical ionization (APCI) interface. A description of the APCI conditions follows. Nebulizer temperature, 220ûC; desolvator temperature, 250ûC; aperture 1 temperature, 170ûC; aperture 2 temperature, 120ûC; needle voltage, 4 kV; drift voltage, 30 V; focus voltage, 30 V. The corresponding NAS and melatonin standards were analyzed similarly by LC-MS under the same conditions.
RESULTS
TPH, AANAT, and HIOMT genes expression
We used human-specific primers for TPH, AANAT, and HIOMT for the RT-PCR amplification of RNA from different tissues and cell lines (Fig. 1A-D) . The sequences of amplified fragments showed complete homology (100%) with the corresponding genes. The 380 bp TPH transcript was present in pituitary, adrenal gland, myometrium, all samples of normal skin, and skin containing basal cell carcinoma. It was also present in cultured normal epidermal and follicular melanocytes, all melanoma cell lines, normal neonatal and adult epidermal and follicular keratinocytes, squamous cell carcinoma cells, and in dermal and dermal follicular papilla fibroblasts. The only cells that tested negative for the transcript were HaCaT immortalized keratinocytes ( Table 1) .
Transcripts of AANAT showed the expected 176 bp fragment spanning exon 2 and 3, and an aberrant 220 bp cDNA fragment corresponding to an isoform with an inserted 59 bp segment from intron 2 (accession number AY055827) (Fig. 1C) . The 176 bp fragment was expressed in the majority of tissues tested, with the exception of a single biopsy specimen of basal cell carcinoma, a single melanoma line (SKMEL188), human follicular melanocytes and immortalized PIG1 melanocytes (Table 1) . Human pituitary and adrenal glands contained, besides the 176 bp fragment, an additional 220 bp aberrantly spliced isoform. The latter isoform was also the sole transcript in a single biopsy specimen of basal cell carcinoma.
RT-PCR amplification for HIOMT showed that human skin samples contain cDNA species of 312 bp and 171 bp, corresponding to the isoform lacking exon 6 and the isoform lacking exons 6 and 7, respectively (Fig. 1D) . The 171 kb HIOMT transcript was expressed in all tissues and cell lines tested. The 312 bp transcript was also expressed in the majority of tissues tested except for a single skin biopsy specimen, and cultured HaCaT keratinocytes, SKMEL188 melanoma and C1-4 squamous cell carcinoma ( Fig. 1D; Table 1 ). An additional HIOMT PCR fragment of 396 bp representing mRNA with all the exons was present in pituitary, adrenal gland, myometrium, epidermal and follicular melanocytes and keratinocytes, dermal and dermal papilla fibroblasts, and selected skin samples (Fig. 1D) .
We also tested the effect of ultraviolet radiation (UVR) on expression of the above genes within the following cell lines: human HaCaT keratinocytes, squamous cell carcinoma C1-4, and SKMEL188 melanoma cells. Although UVR had no effect on TPH gene expression in HaCaT keratinocytes, it did inhibit gene expression in squamous cell carcinoma C1-4 cells and human melanoma cells (Fig. 2) . UVR had no effect on ANAAT expression in any of the three cell lines tested, nor did it change significantly HIOMT gene expression in SKMELL188 cell line (not shown). UVR (5 mJ/cm 2 ) inhibited HIOMT gene expression in squamous cell carcinoma line, whereas, in HaCaT keratinocytes, the same irradiation shifted the splicing pattern. For example, the treated cells produced increased amount of only one HIOMT mRNA transcript, a 510 bp fragment, (GeneBank Accession No. AY037933), as opposed to the two 171 bp and 510 bp PCR bands observed in control cells (Fig. 2) . The 510 bp PCR band represents an aberrantly spliced isoform with the exons 5-7 spliced out and the introns D and F inserted in the final mRNA transcript. Introns D and F have multiple terminator codons that would stop gene translation, resulting in truncated proteins.
Detection of serotonin, 5HIAA, and NAS
Human and hamster malignant melanocytes did show enzymatic activity for conversion of tryptophan to hydroxytryptophan, as shown by direct biochemical assays and immunocytochemistry; this activity level was high when compared with that of the brain (35) . In contrast, HaCaT keratinocytes failed to show tryptophan hydroxylase activity consistent with the absence of gene expression (Table 1) .
Serotonin was detected by immunocytochemistry in immortalized HaCaT keratinocytes (not shown), and its identity was confirmed further by RP-HPLC with electrochemical detection that also identified 5-hydroxyindole-acetic acid (5HIAA) (Fig. 3) . In addition, extracts of human skin subjected to RP-HPLC showed fluorescence at the retention times of serotonin and NAS standards, indicating endogenous stores of the amines. Further investigations with tandem LC/MS were performed in extracts of HaCaT keratinocytes; these showed an adduct ion (M+H) + with mass spectrum and retention time consistent with NAS (m/z at 219 with RT of 14 min; calculated mass was 218 Da) (Fig. 3B) . We made a special search for melatonin in the cell extracts and detected an adduct ion with the same mass spectrum at m/z 233 (calculated mass of 232 Da) and (23 min) as melatonin standard, but at a level slightly above background, which thus only suggested the presence of the indole (Fig. 3C ).
Biochemical detection of AANAT and HIOMT activities
Detection of products of AANAT activity was accomplished in human skin and in all melanomas and immortalized normal melanocytes and keratinocytes by using RP-HPLC system with fluorimetric detection (Figure 4 ; Table 2 ). Thus, extracts of human skin treated with acetyl-CoA transformed serotonin to N-acetylserotonin and tryptamine to N-acetyltryptamine, confirming the presence of the enzyme in the skin and consistent with expression of the corresponding gene. Of interest was the appearance of an unidentified elution peak with retention time of 2.3 min, suggestive of a serotonin or NAS metabolite. These biochemical assays further showed that there were linear relationships between enzyme activity and protein concentration, or between enzyme activity and time of incubation (over a 75-min period) (Fig. 5A, B) . Kinetic analysis of the acetylation reaction by using serotonin as substrate showed the Km and Vmax for human skin of 0.69 ± 0.08 mM and 36.64 pmol/h, respectively (Fig. 5C) . The calculated Km for the same reaction in immortalized melanocytes and HaCaT keratinocytes were 3.96 ± 0.6 and 2.75 ± 0.57 mM with Vmax of 40.64 and 44.3 pmol/h, respectively (Fig. 5D, E) . Comparison of AANAT activities between different cell lines and skin samples showed that, in general, enzyme activity was higher in the melanoma lines, compared with whole skin, immortalized keratinocytes, or immortalized melanocytes ( Table 2 ).
The reaction products of HIOMT activity were separated by RP-HPLC that showed NAS transformation to melatonin in samples of whole skin of either Caucasian or African-American origin (Fig. 6, Table 2 ). HIOMT activity was also detected in HaCaT keratinocytes, and in melanoma cells ( Table 2 ). The identity of newly formed melatonin was verified by its co-elution with authentic melatonin standard. Of note, the RP-HLC chromatogram also showed additional species to melatonin not seen in control extracts; for example, retention times of 7.6, 12, 17.6, 18.8, 19.8, 24, and 28.5 min (Fig. 6B) . Because the species with retention time 7.6, 17.6, 18.8, and 19.8 min, as well as small peak at 24 min, were detected in samples containing NAS without S-adenosyl-L-methionine co-factor, they are likely products of non-HIOMT mediated NAS metabolism, whereas the presence of species with retention time 12, 24, and 28.5 min that were absent in the conditions described in C suggests that these represent products of melatonin metabolism. Although the nature of these compounds remains to be clarified, these findings indicate that NAS may enter either of two alternative metabolic pathways: direct metabolism independent of NAS methylation or progression to melatonin production and rapid, subsequent metabolism.
Discussion
We provide definitive evidence for the expression of an intrinsic capability to transform Ltryptophan to serotonin and to metabolize serotonin to NAS and melatonin in human skin and in cultured skin-derived cells. This conclusion is based on the accumulated results of our experiments demonstrating expression of the TPH, AANAT, and HIOMT genes, metabolism of serotonin to NAS and melatonin, and identification of the intermediate reaction products.
Because the TPH gene was expressed in almost all tested samples (except for HaCaT keratinocytes), it appears that different cellular populations in epidermis and dermis share the potential capacity to hydroxylate L-tryptophan. However, the previously reported selective detection of serotonin in epidermal melanocytes and in melanoma cells (36, 37) suggests that serotonin synthesis in vivo might occur predominantly in cells of melanocytic origin. Within this context, the HPLC identification of serotonin and 5HIAA in HaCaT keratinocytes would then imply that these cells must express serotonin transporters that allow for serotonin cellular uptake and serotonin cellular degradation. The latter was probably mediated by monoamine oxidase and aldehyde dehydrogenase. Indeed, a serotonin transport system has already been described in melanoma cells (37) , and we recently identified 5HTP transporter immunoreactivity in cultured HaCaT cells (not shown). Hence, both paracrine and autocrine mechanisms may co-exist within the epidermal compartment to regulate serotonin availability and its conversion to biologically active compounds. Thus, serotonin produced presumably by melanocytes may be either transformed in situ to NAS and possibly melatonin or released into the extracellular medium to be taken up by keratinocytes for metabolism to NAS and melatonin. This is supported by our detection of AANAT and HIOMT activities in skin and cultured skin cells, detection of NAS in skin samples, and by our identification of NAS and melatonin in immortalized keratinocytes.
AANAT activity was detected in all tested samples (Table 2) , including PIG1 immortalized melanocytes. Because RT-PCR in the latter failed to detect AANAT gene expression, and AANAT activity toward tryptamine was undetectable, we must conclude that this cell line expresses an enzyme isoform that differs from other skin cells (Tables 1 and 2 ; Fig. 1 ). The apparent AANAT Km for serotonin in melanocytes was, nevertheless, similar to keratinocytes, but fourfold higher than in whole skin extract (Fig. 5) . This suggests that AANAT may have varying degrees of affinity for serotonin across the different cellular skin compartments.
Comparative analysis of Km values shows that keratinocyte and melanocyte AANAT is similar to human AANAT expressed in COS-7 cells (2.6 mM), but higher than in bacterially expressed AANAT of human (1.3 mM) or ovine (0.31 mM) origin (38, 39) . In another organ, the ovary, the apparent AANAT Km was calculated as 0.15 mM, which is one-fourth of that in the skin (19) . Thus, serotonin metabolism is highly specific for the existing conditions and dependent on cellular environment in vitro or histological location in vivo. Indeed, the calculated AANAT activity ratios for tryptamine versus serotonin as substrates were close to 1 for all melanoma lines and for HaCaT keratinocytes, whereas they ranged from 2.5 to 6 for whole skin from three white patients (#1-3 in Table 2 ), and were zero in immortalized normal melanocytes and whole skin of a black patient (#4 in Table 2 ) because the enzyme activity toward tryptamine was below detectability. Because AANAT activity for serotonin was higher in melanoma cells than in either whole skin or immortalized normal keratinocytes and melanocytes, both racial background and type of cutaneous pathology (melanoma) may be important determinants of serotonin acetylation rate and specificity. NAS methylation to melatonin was detected in whole skin, in keratinocytes and in malignant melanocytes. HIOMT activity was also detected at levels higher in melanoma cells than in whole skin or keratinocytes. Thus, the human skin is definitely another extrapineal and extraretinal organ with the intrinsic capability to synthesize melatonin (15, (17) (18) (19) 40) . The expression of the HIOMT gene in keratinocytes and melanocytes of epidermal and follicular origin as well as in dermal and follicular papilla fibroblasts implies that melatoninergic pathways may operate independently in the different epidermal, adnexal, and dermal compartments. The unidentified products detected after incubation with NAS indicate that NAS may also enter an alternative metabolic pathway (see insert in Fig. 6B ) or that newly formed melatonin is degraded rapidly. In frog skin, there is an extensive metabolism of melatonin with a rate of degradation even higher than in the brain or retina (41, 42) . Further characterization of those pathways is the subject of our future research that will combine the use of a wide range of metabolic inhibitors with mass spectrometry-derived methods.
UVR is the major cutaneous stressor and is known to affect local production of cytokines and several neuropeptides (43) . We therefore tested the effect of UVR on expression of the genes coding for serotonin/melatonin biosynthesis enzymes in immortalized (HaCaT) keratinocytes, squamous cell carcinoma, and melanoma cells. We could then determine a UVR-induced inhibition of TPH gene expression in squamous cell carcinoma and human melanoma cells and a shift in HIOMT isoform pattern expression in UVR-treated keratinocytes. These results imply that UVR may contribute actively to the regulation of the molecular apparatus responsible for the generation of melatonin from tryptophan. Thus, the selective functional consequences of the solar irradiation on the skin serotoninergic and melatoninergic systems may represent a new research frontier in cutaneous biology.
Serotonin is a recognized neurotransmitter, vasodilator, immunomodulator, and growth factor, while in the skin, serotonin may exert local pro-edema, vasodilatory, proinflammatory, and/or pruritogenic actions (reviewed in 1, 2, 12-15). The ultimate role of serotonin in the regulation of epidermal functions is still unclear, although a report from Paus laboratory appears to indicate that serotonin stimulates epidermal keratinocytes proliferation (44) . As for melatonin, it is known to act as a hormone, neurotransmitter, cytokine, biological modifier, and immunomodulator (15) .In the skin itself, melatonin may inhibit melanogenesis (45, 46) , regulate hair growth (47) , and act as free radical scavenger (48) . Melatonin has also been reported to possess tumorostatic properties toward some rodent melanomas (49) . Within this context, the present demonstrations of local serotonin and melatonin synthesis strongly support the expression of those actions. Such activities may involve para-or autocrine mechanisms, acting in concert in order to regulate skin functions, at a highly compartmentalized level. Thus, the present findings uncover a new layer of potential regulation and deregulation with implications for skin physiology and pathology. Although the full significance of intrinsically produced serotonin, melatonin, and their metabolites is yet to be determined, we must note that we have already detected expression of melatonin and serotonin receptors in cutaneous cells (Slominski et al., unpublished results).
In conclusion, we demonstrate expression of fully developed, local serotonin and melatonin biosynthetic pathways in the human skin. Pathway activities varied, appearing to be dependent on skin cellular compartment, human racial pigmentation, and presence of cutaneous pathology. (+) = positive; (-) = negative; n/e = not evaluated; HF = hair follicle. Experimental: extracts were incubated with N-acetylserotonin and S-adenosyl-L-methionine. B and C) corresponding controls, B extract incubated without NAS, or C extract incubated with NAS, but without S-adenosyl-L-methionine. Retention time for melatonin is marked with an arrow.
